ArticleScience advances2020
The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment.
Szilvia Juhász et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
63 papers cite itlatest 60 shown
this paperpooled itcites it